Go Pro
OTCMKTS:AUGX

Augmedix (AUGX) Stock Price, News & Analysis

Augmedix logo
$2.35 0.00 (0.00%)
As of 10/2/2024

About Augmedix Stock (OTCMKTS:AUGX)

Key Stats

Today's Range
$2.35
▼
$2.35
50-Day Range
$2.35
▼
$2.35
52-Week Range
$0.73
▼
$6.25
Volume
N/A
Average Volume
635,746 shs
Market Capitalization
$115.07 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Augmedix is a healthcare technology company that develops tools designed to reduce the administrative burden associated with clinical documentation. Its platform uses artificial intelligence, natural language processing and, historically, remote medical scribe support to help convert clinician-patient conversations into structured medical notes and other documentation.

The company’s offerings have included Augmedix Ambient AI, which captures and summarizes clinical encounters, as well as products and services intended to support medical note creation, workflow management and integration with electronic health record systems. Augmedix has marketed its solutions to healthcare providers and organizations, primarily in the United States, across areas such as primary care, emergency medicine and specialty care.

Founded in 2012, Augmedix was headquartered in San Francisco and was led for much of its public-company period by Chief Executive Officer Manny Krakaris. Commure announced an agreement to acquire Augmedix in 2024, and the transaction was subsequently completed. As a result, information associated with Augmedix and the OTC Markets symbol AUGX may reflect its historical status as a publicly traded company rather than an independently operating public issuer.

AI Generated. May Contain Errors.

Receive AUGX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Augmedix and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

AUGX Stock News Headlines

Lake Street Downgrades Augmedix (AUGX)
Why I went to Mount Rushmore
A small miner just hit on gold in the hills surrounding Mount Rushmore, thanks to a breakthrough new technology. This could be one of the biggest gold finds since the 1870s, yet the stock still trades around 6 dollars. BlackRock and Vanguard have been quietly loading up on shares while most investors have missed the story. The same technology is unlocking hidden resource wealth across America, driving stocks up 227 percent, 378 percent, and even 773 percent.tc pixel
See More Headlines

AUGX Stock Analysis - Frequently Asked Questions

Augmedix's stock was trading at $2.35 at the start of the year. Since then, AUGX stock has increased by 0.0% and is now trading at $2.35.

Augmedix, Inc. (OTCMKTS:AUGX) issued its quarterly earnings results on Monday, March, 27th. The company reported ($0.15) earnings per share for the quarter, topping the consensus estimate of ($0.16) by $0.01. The firm had revenue of $8.75 million for the quarter, compared to the consensus estimate of $8.52 million. Augmedix had a negative trailing twelve-month return on equity of 980.09% and a negative net margin of 57.70%.

Shares of AUGX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Augmedix investors own include Meta Platforms (META), Urban Outfitters (URBN), Arista Networks (ANET), Capital Southwest (CSWC), NVIDIA (NVDA), PACCAR (PCAR) and Turkcell Iletisim Hizmetleri AS (TKC).

Company Calendar

Last Earnings
3/27/2023
Today
9/26/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Healthcare Technology
Sub-Industry
Healthcare Technology
Current Symbol
OTCMKTS:AUGX
CIK
1769804
Fax
N/A
Employees
710
Year Founded
2012

Profitability

EPS (Trailing Twelve Months)
($0.43)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$24.45 million
Net Margins
-57.70%
Pretax Margin
-57.23%
Return on Equity
-980.09%
Return on Assets
-57.85%

Debt

Debt-to-Equity Ratio
3.74
Current Ratio
1.70
Quick Ratio
1.70

Sales & Book Value

Annual Sales
$51.58 million
Price / Sales
2.23
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.10 per share
Price / Book
23.50

Miscellaneous

Outstanding Shares
48,968,000
Free Float
36,316,000
Market Cap
$115.07 million
Optionable
Not Optionable
Beta
-0.22

Social Links

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

This page (OTCMKTS:AUGX) was last updated on 9/26/2026 by MarketBeat.com Staff.
From Our Partners